Results 1 to 10 of about 33,368 (159)

Role of the Equilibrative and Concentrative Nucleoside Transporters in the Intestinal Absorption of the Nucleoside Drug, Ribavirin, in Wild-Type and Ent1(−/−) Mice

Molecular Pharmaceutics, 2012
Christopher J Endres, Ana Ruiz-Garcia, Doo-Sup Choi   +2 more
exaly  

Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection

Lancet, The, 2001
Alain Lafeuillade, Gilles Hittinger, A Lafeuillade   +2 more
exaly  

Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C

Gastroenterology, 2010
Maria Grazia Rumi, Alessio Aghemo, Roberta D’Ambrosio   +2 more
exaly  

Brain distribution of ribavirin after intranasal administration

Antiviral Research, 2011
Gaia Colombo, Luca Lorenzini, Elisa Zironi   +2 more
exaly  

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

Journal of Hepatology, 2006
Maria Buti, Peter Ferenci, Jan Šperl
exaly  

Isosteric ribavirin analogues: Synthesis and antiviral activities

Bioorganic and Medicinal Chemistry Letters, 2018
M V Chudinov, Andrey V Matveev, Irina D Konstantinova   +2 more
exaly  

Ribavirin

Reactions, 1989
openaire   +1 more source

Ribavirin

Reactions Weekly, 1995
openaire   +1 more source

What future for ribavirin?

Liver International, 2009
exaly  

Utilization of Intravenous Ribavirin Among Reproductive Age Adults in 2010–2017: A Population-Based Study in the Yinzhou District, Ningbo City of China

Frontiers in Public Health, 2021
Background: Intravenous (IV) ribavirin is not approved in US and European Union, but it is authorized in China. Significant teratogenic and embryocidal effects of ribavirin have been found in almost all animal studies, it is critical to investigate the ...
Hailong Li, Houyu Zhao, Hongbo Lin, Peng Shen, Cuili Liu, Siyan Zhan   +5 more
doaj   +1 more source